Investor Information

Medisyn Technologies, Inc. an emerging stage biotechnology company focused on discovering new treatments for cancer, infectious diseases and Alzheimer's disease.

Medisyn has raised over $9 million through private investors and venture capitalists. Key investors include:

Sherpa Partners, LLC
Sherpa Partners, LLC is a Minneapolis-based venture capital firm focused on early-stage companies in the Upper Midwest. We have decades of personal experience in the high-altitude, rarified air of new enterprises. As experienced operational managers, we are investing time, energy and money to help Midwest-based emerging technology companies create the strategies, systems, infrastructure and management teams to become leaders in their markets.

www.sherpapartners.com

Portage Capital
Portage Capital, run by Brad Lehrman and Beatrice Rothweiler, is a business and venture capital consulting firm specializing in emerging growth companies at critical stages of development.

www.portagecapital.com

StarTec Investments, LLC
StarTec Investments, LLC. is a private venture capital firm founded in 1998 by Joy J. Lindsay and Thomas J. McLeod, Sr. The primary investment focus of StarTec is early-stage technology companies located in Minnesota.

Proceeds from future financing will be used to increase the discovery and testing of promising lead drug candidates. Medisyn already has multiple patent-pending therapeutic compounds in its portfolio for license to pharmaceutical partners.

If you are interested in funding opportunities and learning more about Medisyn's technology, please contact:
David Land, President
952-475-8092
dland@medisyntech.com
 
     
 
 
 
 
© 2014 Medisyn Technologies, Inc. Privacy and Terms of Use | 952-475-8084 | Contact Us